89O Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): A randomized, multicenter, prospective, phase III trial
Zhizhong Pan(Sun Yat-sen University), Junjie Peng(Fudan University Shanghai Cancer Center), D-S. Wan(Sun Yat-sen University), Lin Liao(Shanghai University of Traditional Chinese Medicine), Jian Lei(Central South University), Chang Li(Soochow University), P-R. Ding(Sun Yat-sen University), Ye Li(Sun Yat-sen University), Zhen Lu(Sun Yat-sen University), Li Li(Sun Yat-sen University), J-Z. Lin(Sun Yat-sen University), Wei Zhou(Broad Institute), L-H Kong(Sun Yat-sen University), R. Zhang(Sun Yat-sen University), Guangsheng Chen, Xiaojun Wu(Sun Yat-sen University), Wei Jiang(Jiangsu Cancer Hospital), Fang Wang(Chinese Academy of Agricultural Sciences), Wenhua Fan(Capital Medical University)
Cited by 0
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
|Nature Biotechnology|2010|918
Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
|Nature Medicine|2019|367
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256